Does ALECTINIB Cause Neoplasm progression? 124 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 124 reports of Neoplasm progression have been filed in association with ALECTINIB (ALECENSA). This represents 1.4% of all adverse event reports for ALECTINIB.
124
Reports of Neoplasm progression with ALECTINIB
1.4%
of all ALECTINIB reports
27
Deaths
12
Hospitalizations
How Dangerous Is Neoplasm progression From ALECTINIB?
Of the 124 reports, 27 (21.8%) resulted in death, 12 (9.7%) required hospitalization, and 2 (1.6%) were considered life-threatening.
Is Neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ALECTINIB. However, 124 reports have been filed with the FAERS database.
What Other Side Effects Does ALECTINIB Cause?
Death (702)
Fatigue (618)
Constipation (525)
Off label use (495)
No adverse event (488)
Disease progression (366)
Rash (312)
Dyspnoea (296)
Drug ineffective (269)
Myalgia (268)
What Other Drugs Cause Neoplasm progression?
PALBOCICLIB (10,885)
SUNITINIB MALATE (1,920)
CYCLOPHOSPHAMIDE (1,588)
CARBOPLATIN (1,370)
AXITINIB (1,315)
DOXORUBICIN (1,276)
LETROZOLE (1,225)
PACLITAXEL (1,180)
CRIZOTINIB (1,161)
VINCRISTINE (1,106)
Which ALECTINIB Alternatives Have Lower Neoplasm progression Risk?
ALECTINIB vs ALEMTUZUMAB
ALECTINIB vs ALENDRONATE
ALECTINIB vs ALENDRONATE\CHOLECALCIFEROL
ALECTINIB vs ALENDRONIC ACID
ALECTINIB vs ALEVE